EMA launches Website for accelerating EU Clinical Trials
Recommendation
25-27 March 2025
Vienna, Austria
Understand the Implications of becoming a QP
Register now for ECA's GMP Newsletter
The EMA has launched a dedicated website for the Accelerating clinical trials in the European Union (ACT EU) initiative, co-led by the European Commission, the Heads of Medicines Agencies and the European Medicines Agency (EMA). The website contains updates on the progress of ACT EU priority actions, which aim to improve the clinical trials environment in the EU through harmonization, innovation, and stakeholder collaboration.
Key resources include latest information on:
- the Multi-stakeholder platform;
- the implementation of the Clinical Trials Regulation (CTR);
- voluntary procedures in scientific advice;
- the Simultaneous national scientific advice (SNSA) pilot.
In addition, the EMA held a workshop on establishing a multi-stakeholder platform on 22/23 June 2023. Following the workshop, the presentations shown and also the video recordings were published on the EMA website about the workshop.
Related GMP News
20.03.2025EMA Concept Paper on Model Informed Drug Development
20.03.2025End of the Transition Period for Clinical Trials
11.02.2025Final ICH E6(R3) Guideline on GCP released
11.02.2025FDA issues Draft Guidance on Handling Protocol Deviations in Clinical Trials
11.02.2025Further Progress in ICH's Global GMP Harmonization